Inhibition of DDX3 modulates immune signaling in aggressive breast cancers is a research paper published in Cancer Letters (2025). On theSindex it has a DataRank of 0. It has been cited 2 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health National Cancer Institute
Grant: 1R21CA295917
US Office of Congressionally Directed Medical Research Programs
Grant: W81XWH-18-1-0483
NCI NIH HHS
Grant: R21 CA295917
National Institutes of Health
Emerson Collective LLC
U.S. Department of Defense
MeSH Terms
Keywords